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ABSTRACT 
 
PORPHYROMONAS GINGIVALIS GINGIPAINS INDUCE A PRO-
INFLAMMATORY EXTRACELLULAR MICROENVRIONMENT: THE 
ROLE OF PAR-2 AND FIBRONECTIN 
 
Jeffrey S. Marschall 
 
March 16th 2016 
 
Periodontitis is a chronic inflammatory disease that is characterized by 
severe tissue destruction of the gingiva and other tooth supporting structures; if 
left untreated, tooth loss and disintegration of the alveolar bone occurs. This 
chronic inflammatory state has been linked to other systemic diseases such as 
cardiovascular disease, diabetes, rheumatoid arthritis, and Alzheimer’s disease. 
Porphyromonas gingivalis is the major pathogenic microbe in periodontitis.  The 
main virulence factors of P. gingivalis are the Arg-aa and Lys-aa gingipains, 
which are proteolytic enzymes implicated in a plethora of activities that allow P. 
gingivalis to subvert the human immune system in the oral cavity and cause host 
tissue destruction. Here, we report that Arg-aa gingipains, RgpB and HRgpA 
stimulate fibroblasts to express fibronectin, a glycoprotein associated with tissue 
injury and repair, through the transcription of its gene promoter in a dose and time 
dependent fashion. Interestingly, when using a protease activated receptor 2 
antagonists, gingipain induced fibronectin promoter activity was attenuated. 
Furthermore, gingipains stimulate fibroblasts to produce a pro-inflammatory 
matrix triggering production of IL-6 and IL-8 by monocytes that correlated with 
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fibronectin-EDA expression. Taken together, our data suggests Arg-
gingipains act on host fibroblasts to produce fibronectin which, stimulates 
immune cell activation. Taken together, these data suggest that gingipains 
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INTRODUCTION AND SPECIFIC AIMS 
 
 
Periodontitis has been known for nearly 10,000 years as the diet shifted in 
Neolithic (Commonly referred as the “Stone Age”) societies from what was one hunter 
gathers to plant and animal based diets [1, 2]. Periodontitis is a bacterially induced 
chronic inflammatory disease of the gums and other tooth supporting structures (i.e. 
periodontium). The traditional model of periodontitis implies that the disease develops 
when the microbial flora of the oral cavity transitions from healthy to what is considered 
the “red-complex” of pathogenic bacteria made up of Tannerella forsythia, Treponema 
denticola, and Porphyromonas gingivalis. However, recent meta-genomic data suggest a 
more diverse microbial community is involved in pathogenesis [3-6]. The transition from 
physiology to dysbiosis is an emerging area of research. Periodontitis affects millions of 
people and remains a major public health problem; in fact, it has been estimated 30% of 
individuals in developed countries [7] and up to 70% in undeveloped countries [8] have 
reported periodontitis symptoms. Considering this, many epidemiological studies have 
investigated the interplay of periodontitis as a risk factor for respiratory disease, 
cardiovascular disease, diabetes, osteoporosis [8], preterm birth and low birth rate [9, 10]. 
In addition, recent research has proposed a link between kidney disease [11-13], 
rheumatoid arthritis [14-16], Alzheimer’s disease [17, 18], and metabolic syndrome [19-
21]. However, several advances over the past 10 years have changed the wisdom about 
the microbial etiology of periodontitis [22]. More important for administrators, the 
economic cost of periodontitis is quite significant, with estimates ranging from $3.5 to $6 
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billion per annum or $4150 per patient per day [23]. Economic costs for 
periodontal disease are hard to determine, the World Health Organization (WHO) 
estimates that it could be as high as $260 billion in the US alone in 2010 (Data obtained 
from WHO and US Public Health Expenditures) considering 5-10% of public health 
expenditure relates to oral health. It is now well recognized the host response contributes 
significantly to tissue destruction and alveolar bone disintegration [22] which is hallmark 
of periodontitis. The host innate immune system is highly active in healthy tissues, and 
imbalance, corruption, and disruption in the expression of inflammatory mediators 
contributes greatly to the destruction of the tissue and bone supporting the root structures 
[24-26].  Despite periodontal disease’s importance on overall health, public health, and 
economic impact the disease imposes, the exact mechanisms exacerbating periodontitis 
remain unclear. An essential component of the pathogenesis of periodontal disease is the 
destruction of the extracellular matrix (ECM). We hypothesize periodontal pathogens, 
such as P. gingivalis modulate the expression of ECM proteins to promote colonization, 
disease progression, and as a consequence jeopardize host wound healing and immunity. 
In addition we hypothesize, that these effects could be, in-part, mediated by P. gingivalis 
gingipains, and that these ECM interactions may contribute significantly to periodontitis 
progression. This hypothesis will be tested in specific aims designed to: 
 
Aim 1. Examine the mechanisms by which P. gingivalis gingipains corrupt homeostatic 
ECM expression. 
 
Aim 2. Investigate mechanisms underlying P. gingivalis ECM interactions with innate 
immunity






BACKGROUND & LITERATURE REVIEW 
 
PART 1: PERIODONTITIS: ANATOMY, MICROBIOLOGY AND IMMUNOLOGY 
 
Essential to mammalian survival is the ability to efficiently consume foodstuffs 
and convert it to ATP energy. The dentition plays a critical role in this process; thus, 
making the tissues that supports the dentition equally important. The periodontium (from 
the Greek, peri = around and ondontos = tooth) comprises the tissues that support the 
teeth and is made up of the gingiva, periodontal ligament, root cementum, and the 
alveolar bone (Figure 1).  The periodontium is designed to attach the tooth to the bony 
tissue. Together, these tissues form a specific fibrous joint called a gomphosis.    
 
 
Figure 1. The tooth and the periodontium (Image from Ten Cate’s Oral Histology) 
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Collectively, these individual components function together as a single unit. 
Furthermore, the extracellular matrix (ECM) composition can influence the cellular 
activities of adjacent structures. Hence, the pathologic changes that occur in one 
periodontal component can have significant ramifications for the maintenance, repair, and 
regeneration of the periodontium collectively [27].  
Chronic periodontitis is defined as “inflammation of the gingiva and the adjacent 
attachment apparatus. The disease is characterized by loss of clinical attachment due to 
destruction of the periodontal ligament and loss of the adjacent supporting bone [28, 
29]”. The clinical features of chronic periodontitis consist of gingival bleeding, edema 
and more than 1/3 of the supporting periodontal tissue.  
Chronic periodontitis is the most common form of periodontitis [30]. Although 
chronic periodontitis is most prevalent in adults, it can be observed in children. The 
hallmark association of chronic periodontitis is the accumulation of plaque and calculus 
clinically. 
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Figure 2. Clinical Image and 
 Radiographs of plaque-related chronic severe periodontitis with recession (Adapted 
from Carranza’s Clinical Periodontics) 
 
As the plaque accumulates the microbial community shifts from one of 
periodontal health to disease. The symbiotic microbial community within the healthy, 
that is, homeostatic, periodontal sulcus is generally facultative bacteria such as 
Actinomyces and Streptococci. However, in dysbiosis the microbial community consists 
mostly of anaerobic bacteria from the phyla Firmicutes, proteobacteria, Spirochetes, 
Bacterioides, and Synergistetes [2]. These bacteria that facilitate a dysbiotic environment 
have evolved a plethora of virulence factors that allow life in a severely inflamed niche 
[31]. However, this environment can be broken down even further into the sub-gingival 
crevice, the gingival crevicular fluid, and the epithelium lining the crevice. The sub-
gingival crevice is defined as the narrow space between the tooth surface and the free 
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gingiva [2]. Next, gingival crevicular fluid is defined as the serum exudate that originates 
in the gingival capillaries and flows into the gingival crevice carrying local produced 
immune and inflammatory mediators (cytokines and antimicrobial peptides) [2].   
 
Figure 3. Periodontal health with gingival pockets ≤2 mm vs. Periodontal disease with 




The key to periodontal health is to maintain balance of pro-inflammatory 
modulators that in turn, keep a beneficial host-microorganism community the 
periodontium [32]. In periodontitis, the lack of oral hygiene, local factors, or immune-
regulatory defects allow the growth of bacteria that can produce products that allow 
subversion of the immune system and propagation of disease [33]. The destruction of the 
local tissues can further enhance immune-imbalance and create self-perpetuating positive 
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feedback loop. It is important to note that these products from local tissue destruction are 
themselves immune-active.  
 
Figure 4. Schematic of mechanisms associated with periodontitis. (Adapted from 
Hajishengallis [2]).  
 
The bulk of scientific studies investigating the main microorganisms in periodontitis have 
focused on Porphyromonas gingivalis. It is well known that P. gingivalis has the ability 
to produce many virulence factors that allow subversion of the human immune system. 
Traditionally, it was thought that these virulence factors (i.e. gingipains, which will be 
further discussed) were the main culprits in host tissue destruction and thus P. gingivalis 
directly causing periodontitis in animal models [2, 34].  Recent studies have shifted our 
understanding what role P. gingivalis plays within the periodontal microenvironment. In 
fact, it is essential that commensal microbiota to be present, that is, P. gingivalis cannot 
induce periodontitis in germ-free mice alone [6]. This study revealed that while P. 
gingivalis was present in comparatively low amounts compared to other species its 
pathogenicity was due to the ability to induce dysbiotic periodontal microbial 
communities [6]. Hajishengallis and his team referred to P. gingivalis as a keystone 
pathogen [6, 35], that is, certain species are non-pathogenic themselves but when together 
can initiate inflammatory periodontal bone loss.   
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 The innate immune system is multifaceted in its mechanisms of protection 
from infections exogenous microorganisms. The first line of defense is the physical 
barrier provided by the integumentary system, or when considering the oral cavity, the 
gingival epithelium. With this system, defense occurs through the action of keratinized, 
waterproof, epithelium that impedes microorganism penetration to deeper tissues. This 
degree of impermeability is in part due to the evolution of tight junctions, secretion of 
heavily glycosylated mucous, and the secretion of bactericidal peptides (e.g., β-defensins, 
dermicidin, and psoriasin). Furthermore, most of the mucosal and gingival epithelium is 
associated with lymphoid tissues, such as Peyer’s patches that house copious amounts of 
innate and adaptive immune cells.  Considering the gingival epithelium are exposed to 
thousands of commensal and pathogenic microorganisms, these tissues have evolved as a 
very responsive system that aids in the protection of the host, one such mechanism are the 
Toll-like receptors (TLRs), a class of pattern recognition receptors.  
TLRs are expressed by immune and non-immune cells in the oral cavity, and are 
responsible for the recognition of bacterial, viral, fungal, and protozoan molecules. These 
molecules include, but are not limited to, lipopolysaccharide (LPS), bacterial DNA, 
diacyl lipoproteins, and peptidoglycan, among others [36]. Thus far, 13 TLR receptors 
have been characterized in both humans and mice. Some TLRs are located on the cell 
surface, such as TLR-2 and TLR-4, which to date have been the most highly 
characterized; however, TLR-3, TLR-7, and TLR-9, which are nucleic acid detecting 
TLRs [37], can be intracellular and are expressed constitutively [38]. In fact, TLR-2 and 
4 have been implicated in direct recognition of periodontal pathogens such as 
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Porphyromonas gingivalis, Tennerella forsythensis, and Actinobacillus 
actinomycetemcomitans [39, 40].  
 
BACKGROUND AND LITERATURE REVIEW 
PART 2: PORPHYROMONAS GINGIVALIS GINGIPAINS 
Porphyromonas gingivalis has been implicated as one of the main pathogens in 
periodontitis as discussed above. P. gingivalis has several weapons in the form of 
virulence factors. These include bioactive metabolic products, fimbriae and proteolytic 
enzymes [41, 42]. Gingipains, which are cysteine proteases are responsible for up to 85% 
of the proteolytic activity of P. gingivalis [43]. Many studies indicate that gingipains are 
essential for P. gingivalis survival in vivo and experimental infection induction 
(Reviewed by Guo and Potempa [42]). In fact, it has been demonstrated that the 
concentration of RgpB in the periodontal pocket of patients with periodontitis can exceed 
1μM [44].  
Gingipains are classified into two categories: The arginine-specific gingipains, 
RgpA and RgpB, and the lysine-specific gingipain, Kgp. A conserved gene referred to as 
rgpA, rgpB, and kgp encodes each gingipain [45]. RgpA and RgpB share similar caspase-
like protease domain and immunoglobulin-like domain. Both have their catalytic 
specificity towards Arg-aa peptide bonds. RpgA has a third domain, which is a 
hemagglutinin-adhesin domain. Kgp catalytic domain is specific for Lys-aa peptide 
bonds. The hemagglutinin-adhesin domain is absent from RgpB. The gingipains are 
either secreted in their monomeric form (only RgpB) or as a stable complex of protease 
and hemagglutinin-adhesin domain in the form of RgpA and Kgp [42]. Gingipains play 
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an essential role for P. gingivalis from colonization, nutrient acquisition, immune 
subversion and signaling. Each of these gingipain properties will be discussed.  
Gingipains are not the main adhesins of P. gingivalis as fimbriae play the primary 
role; however, gingipains are potent non-fimbrial adhesins nonetheless.  Gingipains bind 
extracellular matrix proteins, such as fibrinogen, fibronectin, laminin and collagen type V 
with high affinity [46]. Pathirana and others have also demonstrated that gingipains may 
mediate tight binding to gingival fibroblasts and epithelium [47, 48]. The hemagglutinin-
adhesin domain exerts most of this binding capacity, of which, the RgpA/Kgp complex 
shows preference to immobilized matrix proteins [49]. These ECM-protease interactions 
may play a critical role in P. gingivalis colonization in the periodontal microenvironment. 
Interestingly, the proteolytic activity of Rgps yields cryptic ligand sites within cleaved 
ECM products that P. gingivalis fimbriae show preferential binding capacity to [50, 51]. 
Gingipains are essential in initial P. gingivalis infection and also play a crucial role in 
nutrient acquisition.  
 
If the host is going to amount a proper attack against P. gingivalis initially, that is 
to say to initiate an inflammatory response, communication between the specific 
components of the innate immune system is required. This is completed via cytokines and 
their respective receptors on host tissues and immune cells. A popular mechanism that 
has evolved is for invading microorganisms to try and disrupt this communication 
between different immune cells and tissues of the host. As for P. gingivalis, gingipains 
play an integral part in cutting off communication in the host immune response. 
Gingipains have been shown to selectively cleave interleukin-1 beta, interleukin-6, 
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interleukin-8, interleukin-12, interleukin-4, interferon-gamma, tumor necrosis factor-
alpha, CD4/CD8 complex, CD14, and intercellular adhesion molecule-1 [52-63]. 
Interestingly, gingipain proteolytic activity may not serve the organism well in all cases. 
For example, interleukin-8 is known to increase neutrophil chemotaxis [64] and 
respiratory burst [65]. However, the 72 amino acid form of interleukin-8 produced by 
local inflammatory cells is easily degraded by gingipains [55] but when epithelial cells 
are exposed to gingipains the less active form of 77 amino acid interleukin-8 they 
produce [66] is converted to the more active form of interleukin-8 [67]. Overtime 
eventually both forms of interleukin-8 were inactivated. Taken together, this suggests a 
relative concentration gradient of gingipains within the periodontium, that is, nearest to 
the periodontal pocket (where gingipains would be in highest concentration) the effect is 
inhibited neutrophil response caused by the degradation of interleukin-8 plus other 
cytokines. Conversely, further away form the periodontal pocket, where presumably 
lower concentration of gingipains would exist, tissue derived (from epithelial cells etc) 77 
amino acid interleukin-8 would be activated to enhance vascular leakage and thus 
increase flow of nutrients to P. gingivalis and the microbial community [68]. Although 
this is just a sampling of the literature describing host immune signaling corruption, it is 
clear that gingipains play an integral role to manipulate hose defense and tailor the local 
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Figure 5. Roles of gingipains in pathological tissue degradation and evasion of host 
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BACKGROUND AND LITERATURE REVIEW 
PART 3: PROTEINASE-ACTIVATED RECEPTORS: PHYSIOLOGY AND 
GINGIPAIN TARGETS 
 
 Considering that proteases make up at least 2% of the human genome [70], it 
makes sense that humans have evolved receptors that capitalize on this enzymatic action. 
Proteinase-activated receptors (PARs) are a family of four seven-transmembrane domain 
G protein-coupled receptors. Unique to PARs is the activation mechanism consisting of a 
tethered ligand that stimulates the receptors when cleaved [71]. New data is emerging 
implicating PARs in several disorders including periodontal disease.  
 PARs are activated by proteolytic cleavage at the N-terminus, which uncovers a 
tethered ligand that interacts with one of the seven transmembrane domain external loops. 
This causes a conformation change that allows for signal transduction [72]. As mentioned 
above, there are currently four known PARs: PAR-1, PAR-2, PAR-3 and PAR-4. 
Thrombin is the endogenous physiological activator for PARs-1,-3 and -4. Whereas, 
PAR-2 is slightly more promiscuous being activated by trypsin, tryptase, coagulation 
factors VIIa, Xa, tissue kalikreins and neutrophil serine protease 3 [42].  PARs play an 
important role in many pathophysiological processes, which include but are not limited 
to, hemostasis, regulation of vascular permeability, vascular smooth muscle contraction 
and bone cell differentiation and proliferation [42, 73].  
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Figure 6. Scheme of the signaling via PARs and cells in the periodontium affected by the 
gingipain-PAR activation. The inactive PAR has an un-cleaved and hidden N-terminal-
tethered ligand sequence. The tethered ligand cannot interact with the body of the 
receptor until it is cleaved at the correct peptide bond (Adapted from Guo and Potempa 
[42]).  
 
 Periodontal tissues express PARs. These cells include oral epithelial cells, 
gingival fibroblasts, mast cells, osteoblasts, vascular endothelial cells, macrophages, 
monocytes, neutrophils, and T-cells [42]. PARs seem to play a critical role in periodontal 
disease considering that PARs play integral roles in innate immunity and bone 
metabolism. For periodontal homeostasis to be maintained, extremely tight regulation of 
host protease-PAR signaling networks is controlled through multiple step cascade 
systems. This is aided by compartmentalization and through endogenous protease 
inhibitors [42]. However, once pathogenic plaque biofilm starts to accumulate, gingipains 
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concentration increases and host proteolytic cascades are undermined. The balance is 
shifted towards one that is increasingly inflammatory as host neutrophils begin to 
accumulate begin releasing their own proteolytic enzymes. Furthermore, gingipains can 
themselves cause cellular action via PAR cleavage further complicating the picture 
(Table 1).  










































































Keratinocytes PAR-1, PAR-2 
Rgp 
Up-regulation 
of the HIV-1 
co-receptor 
CCR5 
Promotion of HIV 
infection of oral 
keratinocytes 
[81] 
  16 
Oral epithelial 
cells 
PAR-2 Rgp Induced 
expression of 
human beta 























IL-8 in response 
to LPS.  
Enhanced pro-
inflammatory 
responses to P. 



















PARs Rgp Kgp Up-regulation 



















































Table 1. PARs targeted by gingipains and the consequence of their action (adapted from 
Guo and Potempa [42] 
 
  17 
  It is obvious that host proteases-gingipains-PAR signaling have many cellular 
effects. However, we must consider how this signaling axis plays into overall disease 
progression. PAR-1 and PAR-2 activation lead oral epithelial cells to produce IL-1alpha, 
IL-1beta, IL-6 and TNF-alpha and IL-8; in addition, monocytes release a similar pro-
inflammatory cytokine profile when treated with Rgps [84]. Neutrophil activation via 
PAR-2 by gingipains also increase the expression of IL-1beta, IL-6, and IL-8 [74]. Not 
only do gingipain-PAR signaling enhance the expression of pro-inflammatory cytokines, 
they also induce the expression of mediators that are responsible for bone turnover. Oral 
fibroblasts when stimulated via PAR-1 and PAR-2 expressed hepatocyte growth factor, 
which is known to increase osteoclast activity. Furthermore, cytokines themselves can 
drive bone resorptive activities and this may be synergized by gingipains-PAR signaling 
via receptor activator of nuclear factor Kappa beta ligand (RANKL)/osteoprotegrin 
expression ration in osteoblasts [89]. For normal bone turnover to occur, osteoblasts most 
control osteoclastogenesis via tight control via RANKL (Stimulator of 
osteoclastogenesis) /Osteoprotegrin  (inhibitor of osteoclastogenesis) expression. This 
balance is further undermined by P. gingivalis Kgp, which degrades osteoprotegrin [90].  
 Considering the signals that are released when PARs are activated by invading 
bacterial proteases, it is clear that they play an essential role in the surveillance of 
periodontal tissues [42]. However, periodontal pathogens are resistant to PAR mobilized 
innate immune cells [42]. Interestingly, one PAR has stood out to have an essential role 
in the pathogenesis of periodontitis. Several studies have demonstrated that PAR-2 plays 
a pivotal role in experimental periodontitis. One example, oral challenge with a PAR-2 
agonist not only increased existing periodontitis in rats, but also caused the development 
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of the disease with the clinical hall marks of alveolar bone loss, gingival granulocyte 
infiltration accompanied by the overexpression of matrix metalloproteinase (MMP)-2, 
MMP-9, cyclooxygenase 1 and cyclooxygenase 2 [91]. Furthermore, Wong and team 
demonstrated PAR-2 knockout mice orally infected with P. gingivalis showed 
significantly reduced or no alveolar bone loss when compared to wild-type or PAR-1 
knockout P. gingivalis infected mice [92]. The lack of alveolar bone loss in the PAR-2 
knockout mice was followed by a large decrease in the infiltration of mast cells and type 
1 helper T-cell dependent cytokines, such as interleukin-2 and interleukin-17 and TNF-
alpha [92]. Considering these studies, there is no doubt about the important role PAR-2 
plays in periodontal disease. The picture becomes more complicated when we consider 
the layers to PAR-2 activation. The first layer of PAR-2 activation is completed by the 
arginine specific gingipains. As discussed above, this leads to the expression of 
inflammatory cytokines, such as interleukin-6, that directly enhances bone resporption 
via osteoclasts [77, 92]. Another layer we need to consider is mast cells, which also 
recognize P. gingivalis. The mast cells could release tryptase, which can additionally 
activate PAR-2. Furthermore, mast cells can release TNF-alpha further adding to the 
inflammatory milieu [92]. Lastly, neutrophil infiltration would lead to the increase of 
proteinase-3, which also is known to activate PAR-2 [92, 93]. Considering that all three 
of these avenues of activation of PAR-2 could lead to T-cell involvement, it is no surprise 
that PAR-2 knockout mice lack the hallmarks of periodontitis. PAR-2 could be a 
potential therapeutic target in periodontitis.  
 Due to PARs unusual mechanism of action, that is the tethered ligand, a multitude 
of strategies has been used to develop antagonist. Ramachandran and colleagues 
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emphasized that the term antagonist is used loosely and doesn’t necessarily fit the 
classical pharmacological definition [71]. The approaches used to abrogate PAR receptor 
signaling include: 1) blocking the docking of the tethered ligand sequence with a small-
molecule receptor antagonist, 2) occluding the cleavage site of the tethered ligand with a 
PAR-selective antibody that prevents proteinase activation, or 3) interfering with the 
interactions between a PAR and its intracellular signal transduction proteins [71].  The 
therapeutics developed with these ideas are progressing; PAR-1 antagonists (Vorapaxar 
and Atopaxar) are late state clinical trials where as PAR-2 antagonists (i.e. ENMD-1068) 
are still being validated in animal trials [71].   
 Developing of a small-molecule non-peptide PAR-2 antagonist has not 
been as straightforward as it was for PAR-1. Two peptides were found to block trypsin 
induced PAR-2 signaling but not by PAR-2 activated peptides [94]. The PAR-2 
antagonist peptide ENMD-1068 (N1-3-methylbutyryl-N4-6-aminohexanoyl-piperazine; 
Figure 8), which is used in this study, is also based on the tethered ligand motif of PAR-
2. Ferrell and colleagues demonstrated that ENMD-1068 blocked trypsin-mediated 
receptor activation and attenuated PAR-2 mediated murine joint inflammation in vivo 
[95]. Unfortunately, in a clinical setting ENMD-1068 was not potent enough to match the 
preclinical results [96].  Taken together, PARs represent a relatively new avenue of 
therapeutic intervention in a host of diseases where inflammation plays a critical role. 
One avenue that has yet to be discussed is the role of the extracellular matrix plays in 
inflammation and periodontal disease.  
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Figure 7. Currently available Proteinase activated receptor antagonist. PAR-1 
Antagonist: BMS-200261 (Used in this study), RWJ56110 and RWJ58259, FR17113, 
F16618, and F16357. PAR-2 Antagonist: GB88, ENMD-1068 (Used in this study), AC-
264613, AC-55541, K14585. PAR-4 Antagonist: YD3. (Adapted from Ramachandran et 
al [71]).   
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BACKGROUND AND LITERATURE REVIEW 
PART 4: THE EXTRACELLULAR MATRIX 
The extracellular matrix (ECM) consists of the secreted products of many cell 
types that form an organized scaffold for cellular support [97]. The ECM exists in many 
different biochemical and structural forms and its architecture is the product of 
extracellular and intracellular assembly from several cell types. The contents of the ECM 
are highly insoluble proteins that are made of specific conserved domains. Often, these 
domains contain relatively large amounts of glycosaminoglycans and sulphate leading to 
an overall negative charge [98, 99]. The negative charge and large surface area yields a 
plethora of interactions with other charged molecules such as growth factors and 
chemokines, effectively controlling the local concentration and accessibility to cells in 
close proximity [99]. 
The ECM can take two basic forms. These are the basement membrane or the 
interstitial matrix form. The basement membrane is a complex of thin networks of highly 
cross-linked glycoproteins. The interstitial form is loose and fibril like. Furthermore, 
there is specialized ECM structures that have a combination of both of the 
aforementioned forms, that is, the reticular fibers, which make up lymphoid organs [97]. 
Lastly, Eckes and others described a provisional matrix form that can be well-populated 
by immune cells during wound healing [100].  One of the main barriers immune cells 
have on their way to the site of infection is the basement membrane.  
Tissue dynamics, that is its formation, function and regeneration after damage as 
well as its function in pathology is the result of an intricate interplay of temporal and 
spatial coordination of numerous individual cell fate processes, each of which is induced 
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by a myriad of signals originating from the ECM [101]. The extracellular milieu consists 
of a plethora of complex array of biophysical and biochemical signals that when bound to 
their respective receptors ultimately transduce an intracellular cascade that converges to 
regulate gene expression and cell phenotype [101]. The ECM, which surrounds cells and 
comprises the molecular signals, is a highly hydrated network hosting three main 
effectors: 1) insoluble hydrated macromolecules (Proteins such as collagen and 
fibronectin) 2) Soluble macromolecules (Growth factors) and 3) Proteins on the surface 
of neighboring cells (Integrins) [101]. Final cell fate, which is cellular differentiation, 
proliferation, migration or apoptosis, is the result of the individual cell and the molecular 
interactions with the ECM effector molecules [101].  
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Figure 8. The behavior of individual cells and the dynamic state of the 
multicellular tissues is regulated by reciprocal molecular interactions between cells and 
their surroundings (From Lutolf and Hubbell [101]. 
   
 The ECMs most elemental function provide nearby cells a structural scaffold that 
can resist tensile and compressive stress [101]. Structural ECM proteins include different 
forms of collagen. Some collagens are long and stiff while and function as structural 
proteins, whereas others serve connecting and recognition functions [101].  The fibrillar 
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structure of ECMs has been demonstrated to effect integrin clustering thus altering 
cellular behavior [101, 102]. The ECM provides bound adhesion ligands, which include 
fibronectin and vitronectin, that guide the development and maintenance of cell function 
[101]. The integrins, a family of transmembrane, heterodimeric, cell-surface molecules, 
function as the principle receptors of cells for many of these ECM adhesion molecules 
[101].  Integrins primarily link the macromolecules of the ECM with the cell’s 
cytoskeleton, but are involved in cell-cell adhesion and binding to proteases, such as 
matrix metalloproteinase [101].  When bound to ECM ligands, integrins cluster and form 
associations with various signal-transducing molecules (PI3K etc.) to activate specific 
protein kinases such as mitogen activated protein kinase. Thus, integrins play an 
important role in relaying information from the cellular surface to genome, which 
ultimately brings about a phenotypic change [101, 103, 104].  
 Fibronectin is a large dimeric (2 x 230kDa) ubiquitous extracellular matrix 
protein [105]. Fibronectin is also present in the gingiva and periodontal ligament where it 
has multiple functions like those described in the previous paragraph [106].  P. gingivalis 
use its gingipains to proteolytically cleave integrin-gingipains interactions on fibroblast 
cell surface [107].  Previous studies demonstrate that gingival fibroblasts when co-
cultured with a high concentration of purified gingipains lead to a decrease in fibronectin 
and α5β1 integrin, causing cell detachment and cell death [108]. Not surprisingly, 
samples taken from patients with periodontitis demonstrated increased amounts of 
fibronectin fragments, the result of host and pathogen proteolysis [109, 110]. Specially, 
the 120, 68 and 40 kDa, fibronectin fragments that include the main cell and heparin 
binding regions were greatly increased in periodontitis [109]. Feghali and Grenier 
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demonstrated that the smaller fibronectin fragments of 30 and 45 kDa were the most 
potent inflammatory inducers as they dose-dependently increased secretion of TNF-α, IL-
1β, and IL-8 in human macrophages [110]. The 120-kDa fibronectin fragment did not 
induce the secretion of those same cytokines; whereas the whole 420-kDA fibronectin 
only increased IL-8 [110]. In addition, this study also demonstrated that the Arg and Lys 
specific gingipains purified from P. gingivalis modulate fibronectin fragmentation [110]. 
Furthermore, cellular fibronectins contain alternatively spliced exons encoding type III 
repeat extra domain A (fibronectin-EDA) and EDB are produced in response to tissue 
injury [111-113]. The response of cells exposed to recombinant EDA or EDA-containing 
fibronectin are similar to those observed when cells are treated with LPS, that is, they 
produce pro-inflammatory cytokines and other proteins such as matrix metalloproteinase 
[111-113].     
 Matrix metalloproteinases (MMPs) are a class of zinc dependent endopeptidases 
that consist of four conserved protein domains, which include the pro-domain, catalytic 
domain, haemopexin domain and the C-terminal domain. MMPs expression is regulated 
by pro-inflammatory cytokines, growth factors, and hormones [114-116]. MMPs are 
secreted as zymogens that require activation by removal of the amino terminal pro 
domain [117]. Interestingly, MMPs can reciprocally activate other MMPs and by furins 
[97]. However, the most important player is MMP regulation is the tissue inhibitor of 
metalloproteinase, or TIMPs, that bind and inactivate most MMPs. Importantly, MMP 
mRNA expression or even protein expression does not provide information on the in vivo 
localization of MMP activity, which is assessed by in situ gel zymography [118]. MMPs 
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are classified by their substrate that they can cleave that are identified by in vitro 





Figure 9. Potential modes of ECM-mediated activation of immune cells (Adapted from 
Sorokin [97]. 
 
The amount of evidence is increasing that demonstrates ECM turnover, by host or 
bacterial proteases, can act as chemo-attractants themselves that can alter immune cell 
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activity [97].  ECM fragments from type 1 collagen generated by proteolytic cleavage by 
MMP-8 or MMP-9 has been shown to have the same pro-inflammatory effects as a well-
known pro-inflammatory stimuli, CXCL8, on neutrophils in lung inflammation [119]. In 
addition, MMP-12 and elastase generated from elastin induce chemotaxis in a model 
focused on monocytes in chronic inflamed lungs [120]. One of the main culprits that play 
a role in ECM induced activity of immune cells are the Toll-like receptors, which 
recognize defined molecular patters that are usually associated with pathogens and tissue 
damage. Activation of TLRs causes the activation of innate immune pathways which will 
ultimately have an effect on adaptive immune responses [97]. Data currently implicates 
fragments of the ECM as activators of TLR-4. Most of the data currently available has 
shown that the molecules involved are either up regulated or proteolytically processed in 
inflamed tissues and are mostly interstitial matrix molecules such as tenascin C, 



















PORPHYROMONAS GINGIVALIS GINGIPAINS INDUCE A PRO-INFLAMMATORY 




Periodontitis is a widespread chronic inflammatory disease of the periodontium. It has 
been estimated that 50% of adults greater than 30 years of age have manifestations of the 
disease in the United States [7]. If left untreated, gingival destruction, loss of alveolar 
bone, and eventually tooth loss will occur. In addition, periodontitis has been correlated 
as a risk factor with respiratory disease, cardiovascular disease, diabetes, osteoporosis 
[8], preterm birth and low birth rate [9, 10] Periodontal pockets, which are hallmark of 
periodontitis, allow for persistent anaerobic conditions that facilitate the colonization 
anaerobic pathogens such as Porphyromonas gingivalis. P. gingivalis is the causative 
pathogen for both adult periodontitis [124].  P. gingivalis posses an array of putative 
virulence factors that include lipopolysaccharide (LPS), fimbriae, toxic metabolites, and 
proteolytic enzymes; all of which stimulate the host immune system, inflammatory 
mediators, and promote periodontitis. Essential to P. gingivalis virulence are the 
proteolytic enzymes termed gingipains, which allow P. gingivalis to subvert the human 
immune system [125]. 
Here, we studied the proteolytic activity of two cysteine proteinases produced by 
P. gingivalis [126]. The arginine specific gingipains, RgpB and HRgpA, of 50 and 95 
kDa which only cleave peptide bonds at Arg residues [127], and the lysine specific 
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gingipain, Kgp, of 105 kDa which cleaves specifically at Lys residues [128]. HRgpA and 
Kgp consist of a catalytic domain and a hemaglutinin/adhesion domain, which RgpB 
lacks. Gingipains take part in a plethora of physiological activities which have been 
shown to enhance vascular permeability through activation of the kinin pathway [129], 
activate complement [130], disrupt blood plasma clotting [131, 132] and cleave CD14 on 
human monocytic cells [133].  
During inflammation and periodontal pocket formation, the extracellular matrix 
(ECM) becomes assessable to P. gingivalis gingipains. The periodontal ECM is made up 
of a plethora of proteins, such as collagen and fibronectin. The ECM and its 
corresponding network of proteins not only provides structure support, but also play a 
vital role in cell adhesion, migration, signaling, and ultimately cell survival. ECM and 
gingipain interaction has been shown to be important for colonization, that is, 
P.gingivalis preferentially binds to immobilized fibronectin (FN) in vitro [49]. FN is an 
essential adhesive glycoprotein that is important in physiologic and pathologic conditions 
associated with tissue injury and repair and a major component of the ECM. FN exists as 
either as an insoluble glycoprotein which polymerizes adding structure support, or 
alternatively, exists as a soluble disulphide-linked plasma protein which plays a more 
direct role in wound healing [134]. Both of which are found during tissue repair, cell 
migration, embryogenesis, and blood clotting. In addition, different splice variants, such 
as extra domain A of fibronectin (Fibronectin-EDA) can have vastly different biological 
activities. EDA of fibronectin stimulates toll-like receptor (TLR) 4 and induces NF-κB 
activation [113] In addition, during infection and inflammation, proteolytic cleavage of 
the ECM occurs; this has been well documented during rheumatoid arthritis [113, 135, 
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136]. In addition, it has also been demonstrated in other systems that degraded ECM 
molecules stimulate the host cells in the site of infection to produce a multitude of 
inflammatory cytokines [135, 137-142]. Considering FN fragments have been detected in 
vivo from lung lavages, individuals with periodontal disease [143, 144] a significant 
effort has been made towards the elucidation of the biologic activities of specific FN 
fragments. For example, 30kDa N-terminal FN fragments had greater chemotactic 
activity for monocytes when compared to un-fragmented FN and even decreased 
monocyte attachment to fibrin [145].  
It has been established that bacterial adhesion/degradation of fibronectin is 
important in the virulence of different bacteria. For example, adhesion of fibronectin 
promotes the colonization of Mycobacterium tuberculosis to murine alveolar 
macrophages [146] and Streptococcus pneumioniae in meningeal inflammation [147]. In 
contrast, FN proteolysis provides a source of fermentable fuel [148, 149], or conversely, 
may jeopardize host wound healing [150]. Furthermore, interactions with FN allow 
pathogens to penetrate host tissues, thus avoiding some of the host immune system [151]. 
In addition, fibronectin binding has been shown in oral pathogens such as Treponema 
denticola [152].  In addition, the causative microbe of syphilis, Treponema pallidum, also 
interacts with FN [153]. Less is known about the specific molecular interactions P. 
gingivalis has with secreted ECM proteins such as fibronectin and the effect on the 
regulation of their corresponding genes. In addition, the downstream affect of pathologic 
proteolysis of ECM proteins, in particular fibronectin and the overall pathogenesis of 
periodontitis and the consequences for overall systemic health have yet to be elucidated. 
 




MATERIALS & METHODS 
Reagents and Cell Culture 
NIH 3T3 fibroblasts and human gingival fibroblasts (ATTC, CRL-2014) were grown in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS; Atlanta Biologicals, Lawrenceburg, GA) 50 IU/ml penicillin/streptomycin 
and 1mg amphotericin (Corning Cellgro) at 37°C in a humidified 5% CO2 incubator. 
U937 monocytes were incubated in RPMI-1640 supplemented with 10% fetal bovine 
serum (FBS; Atlanta Biologicals, Lawrenceburg, GA) 50 IU/ml penicillin/streptomycin 
and 1mg amphotericin (Corning Cellgro) at 37°C in a humidified 5% CO2 incubator.  
Purification and activation of gingipains 
RgpB, HRgpA, and Kgp were purified from P. gingivalis HG66 culture supernatant, as 
described previously [128, 154]. Purity of each enzyme purification was checked by 
SDS-PAGE. In a 10% Tricine gel (Von Jaggow), RgpB showed a single band with an 
apparent molecular weight of 48kDa and the purity was > 95% as determined by laser 
densitometry scanning of the gel. HRgpA was composed of four major and one minor 
band on SDS-PAGE and each protein band was identified as a HRgpA component by N-
terminal sequence analysis [128]. The amount of active enzyme from each gingipain was 
determined by active site titration using FPR-cmk and Z-FK-cmk for Rgps and Kgp, 
respectfully [43]. The concentration of fully activated gingipains with cysteine was 
calculated from the amount of inhibitor needed for complete inactivation of the 
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proteinases. The gingipains were activated in 0.2M HEPES, 5mM CaCl2, and 10mM 
cysteine, pH 8.0, at 37°C for 10 minutes, and then diluted in media or buffer. To block 
enzymatic activity, activated gingipains were incubated with a 10mM concentration of 
KYT-1, (3S)- N- [(1S)- 5- Amino- 1- (N,N- dimethylcarbamoyl)pentyl]- 3- [(2S)- 6- 
amino- 2- (benzyloxycarbonyl) aminohexanoylamino]- 6- guanidino- 2- oxohexanamide,  
(PeptaNova, Germany).  
Assay for fibronectin gene promoter activity 
To evaluate fibronectin gene expression, NIH 3T3 cells expressing pFN(1.2kb)LUC 
containing ~1,200bp of the 5’-flanking region of the human fibronectin gene isolated 
from the human sarcoma cell line HT1080 were used. This construct includes 69bp of 
exon 1, a CAAT site located at -150bp, and the sequence ATATAA at -25bp from the 
transcription start site. It also contains several previously identified regulatory elements 
such as three cAMP response elements located at -415, -270, -170, and an SP-1 site at -
102bp from the transcriptional start site. The promoter was sub-cloned in the Sma I site of 
pGL3 Basic Luciferase reporter vector (Promega, Fitchburg, WI). The pFN(1.2kb)LUC 
promoter construct was introduced into murine NIH 3T3 fibroblast via electroporation to 
create a stable transfectant. Fibroblasts were maintained in DMEM with 4.5g/l glucose 
supplemented with 10% heat-inactivated FBS and 1% antibiotic-antimycotic solution 
(100U/ml penicillin G sodium, 100U/ml streptomycin, and 0.25µg/ml amphotericin B) 
and incubated in a humidified 5%CO2 incubator at 37°C. The cells were then treated with 
a 1:400 dilution of RgpB or a 1:100 dilution of HRgpA isolated for P. gingivalis for 2, 4 
or 6 or 24 hours at varying concentrations. Afterward, the cells were tested for luciferase 
activity. For this, the cells were harvested by scraping, washed with PBS, resuspended, in 
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100µl of cell lysis buffer (Promega, Fitchburg, WI), sonicated, and a 20µl aliquot was 
tested by adding 50µl Luciferase assay reagent (Promega, Fitchburg, WI). Light intensity 
was measured using Labsystems Luminoskan Ascent Plate Luminometer. Results were 
recorded as normalized luciferase units adjusted to total protein concentration (Bradford 
method).   
Western Blot Analysis 
For western blotting of fibronectin, NIH 3T3 cells were treated with a 1:400 dilution of 
RgpB at 50, 100 or 200nm concentration or control and allowed to incubate at 37°C for 
24 hours. The cells were lysed in homogenization buffer (50mM β-glycerophosphate, pH 
7.4, 1mM EGTA, 1mM DTT, 2mM PMSF, 0.1mM sodium vanadate). Protein 
concentration was estimated by the Bradford method. 75μg of protein was loaded from 
each sample into a 5% SDS-polyacrylamide gel with a 3.9% stacking gel and ran at 150 
volts for 1.5 hours. The separated proteins were transferred onto a nitrocellulose 
membrane using a BioRad Trans Blot Semi-dry transfer apparatus for 2 hours at 25 volts. 
The gels were blocked with 5% non-fat dry milk (0.5% Tween-20 and 10% 10xTBS) for 
1 hour at room temperature and washed three times for 5 minutes with wash buffer (1x 
TBS, 0.5% Tween-20). The blots were incubated with primary antibody against 
fibronectin (Sigma, St. Louis, MO; 1:1000 dilution) overnight at 4°C. The blots were 
then washed 3 times for 5 minutes with wash buffer and incubated with secondary 
antibody to rabbit anti-goat IgG (Santa Cruz Biotechnology, Inc., Santa Cruz, CA; 
horseradish peroxidase-conjugated 1:20000) for 2 hours at room temperature. GAPDH 
(1:5000) was used as a loading control. Blots were developed using ECL solution (GE 
  34 
Healthcare, formerly Amersham Pharmaceuticals). Protein bands were quantified by 
densitometry using laser densitometer (BioRad, GS-800).  Means are reported ± SD.  
Gelatin zymography 
CHAPS buffer (0.15M NaCl, 10mM CHAPS, 20mM HEPES pH 7.5, 1mM 
EDTA, 2mM PMSF) was added to cell samples. Total protein concentration was 
determined using the Bradford method. 9% zymography gels were prepared with a final 
concentration of gelatin (Sigma Chemical Inc., St.Louis, MO) approximately 1mg/ml. 
The zymography gels were in 1x SDS-Page gel running buffer on ice at 50 volts for 30 
minutes followed by 100 volts for an additional two hours. The gels were then incubated 
for 60 minutes in 2.5% Triton x-100 in distilled water at ambient temperatures. The gels 
were then incubated overnight at 37°C in substrate buffer (50mM Tris pH 8.8, 10mM 
CaCl2), which activates the gelatinase MMPs. Next, the gels were stained with 0.5% 
Coomasie blue R-250 in water/methanol/acetic acid (45:45:10) for 30 minutes followed 
by destaining with 50% methanol, revealing the MMP bands while the rest of the gel 
remained stained. The MMP bands were quantified using a Bio-Rad laser scanner GS-
800 densitometer. Data obtained was analyzed using one-way ANOVAs, and post hoc 
multiple comparisons, if warranted (Bonferrroni’s Multiple comparison Test).  
Testing the effect of fibroblast-derived ECM 
Fibroblasts were cultured for 5 days, when confluence was reached in 6-well Costar cell 
culture plates (Corning). Afterwards, the fibroblasts were eliminated by osmotic lysis. 
Cells were washed once with PBS containing 1mM EDTA (3A solution), then treated for 
30 minutes at 4°C with the 3B solution (0.25M NH4OH, 1mM EDTA, 1mM PMSF). The 
cells were washed two additional times with solution 3A and then treated for 15 minutes 
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at 4°C with solution 3E (1M NaCl in 50 mM Tris (pH 7.4), 1mM EDTA, 1mM PMSF). 
Lastly, the culture plates were washed once with solution 3A. Isolated matrices were 
stored at 4°C with PBS. Matrix isolation was confirmed via direct immunoflouresnce of 
fibronectin.  
 Human monocytic U937 cells permanently transfected with the human IL-1β gene 
promoter fused to a luciferase reporter gene [155] were incubated in RPMI (Cellgro) on 
matrix-coated plates for 24 hours. Afterwards, the cells were harvested by scraping, 
washed with PBS, resuspended, in 100µl of cell lysis buffer (Promega, Fitchburg, WI), 
sonicated, and a 20µl aliquot was tested by adding 50µl Luciferase assay reagent 
(Promega, Fitchburg, WI). Light intensity was measured using Labsystems Luminoskan 
Ascent Plate Luminometer. Results were recorded as normalized luciferase units adjusted 
to total protein concentration (Bradford method).   
Enzyme Linked Immunosorbant Assay 
Enzyme linked immunosorbant assays (ELISAs) 96-well plates were pre-coated by the 
manufacturer with either human IL-6 or IL-8 antibodies from the manufacturer (Thermo 
Scientific, Rockford, IL). The manufactures instructions were followed. Before all 
experimental samples were tested, positive control was tested to make sure the value did 
not exceed the highest value of the standard curve (400pg/ml). All reagents were 
prepared fresh for each experiment. 30mL of 30x “Wash Buffer” was added to 870mL of 
sterile water for each plate used and was mixed thoroughly. Wash buffer was at room 
temperature before use in all assays. Standards for IL-6 or IL-8 were reconstituted with 
lyophilized standard. Standards were prepared using serial dilutions (contained 0.1% 
sodium azide). For IL-6 the standard dilutions were 400pg/ml, 160pg/ml, 64pg/ml 
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25.6pg/ml, 10.24pg/ml and 0pg/ml. For IL-8 standard dilutions were 1000pg/ml, 
400pg/ml, 160pg/ml, 64pg/ml 25.6pg/ml, 10.24pg/ml and 0pg/ml. 50μL of biotinylated 
antibody reagent were added to each unknown sample well. 50μL of standards were 
added to the wells in duplicate. Plate was covered and allowed to incubate at room 
temperature for two hours. Plate was washed three times using wash buffer. 100μL of 
prepared streptavidin-HRP solution was added to each well. Plate was covered and 
allowed to incubate at room temperature for 30 minutes. Plate was then washed three 
times with wash buffer. 100μL of TMB substrate was added to each well and allowed to 
develop in the dark at room temperature for 30 minutes. The reaction was stopped by 
adding 100μL of stop solution (contains 0.16M sulfuric acid) to each well. Absorbance 
was measured with a plate reader set at 450nm. Results were calculated using Excel 
(Microsoft) and data was fit to the standard generated curve. Means are reported ± SD.  
 
Immunofluorescence staining of fibronectin 
Primary mouse lung fibroblasts were grown in 8-well chamber slides for 72 hours. After 
treatment with gingipains for 24 hours, media was aspirated and cells were covered with 
warm 4% paraformaldehyde in PBS for 15 minutes. Once cells were fixed, cells were 
incubated with blocking buffer (1x PBS, 5% normal goat serum, 0.3% Triton X-100) for 
60 minutes. Blocking buffer was aspirated and cells were incubated with primary 
antibody against fibronectin-EDA (1:200; Sigma, St. Louis, MO) in antibody dilution 
buffer (1x PBS, 1%BSA, 0.3 Triton X-100) overnight at 4°C. Afterward cells were then 
washed 3 times with PBS. Cells were incubated with flourochrone-conjugated secondary 
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antibody (FITC) for 1 hour at room temperature in dark. DAPI was added at 1:5,000 in 
methanol for 5 minutes. Slides were mounted, cover slipped and examined.    
Screening for lipopolysaccharide (LPS) 
In order to avoid any confounding effects from LPS contamination, all treatment 
materials and culture media were screened with a limulus based endotoxin assay with a 
sensitivity of 0.06ng/ml (Lonza, Basel, Switzerland). 
Statistical Analysis 
Means plus standard deviations of the mean were calculated for all experimental values. 
To establish statistical significance, one-way ANOVAs were performed on data taken 
from experiments. Post-hoc multiple comparisons performed, if warranted (Bonferroni’s 
Multiple Comparison Test). GraphPad Prism was used to analyze data (Software 


















Gingipains stimulate the expression of fibronectin through PAR-2 
We first evaluated the effect of purified gingipains on the expression of 
fibronectin in fibroblasts using NIH 3T3 cells transfected with the human fibronectin 
gene promoter fused to a luciferase reporter gene.  As depicted in Figure 1, we found that 
the Arg-specific gingipains, RgpB and HRgpA, greatly stimulated fibronectin gene 
expression; both RgpB and HRgpA stimulated fibronectin gene expression in a time- and 
dose-dependent manner when compared to control (Fig. 1A and B, respectively). 
Interestingly, both RgpB and HRgpA stimulated the fibronectin promoter approximately 
equally. When in the presence of KYT-1, a selective inhibitor of gingipain enzymatic 
activity, the observed effects were completely abrogated.   
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Figure 1. Gingipains induce fibronectin gene expression. (A) Dose dependent 
response of NIH 3T3 cells (1.5x105 cells) permanently transfected with the human 
fibronectin promoter were incubated with 50, 100, 200, or 400nm of RgpB, HRgpA, or 
RgpB or HRgpA plus KYT-1 (10M) inhibitor for six hours at 37°C. Purified gingipains 
were pre-incubated with or without KYT-1 for 15 minutes at 37°C. Luciferase readings 
were taken after 6 hours. (B) Time dependent response of the human fibronectin 
promoter in NIH 3T3 cells  (1.5x105 cells) stimulated with 50, 100, 200, or 400nm RgpB, 
HRgpA, or RgpB or HRgpA plus KYT-1 (10M) inhibitor for 2, 4, 6, and 8 hours. Data 
depicted as means ± SD. Overall P<0.0001 (One-way ANOVA). Bars and asterisks 
indicated post-hoc comparison significance (P <0.05). 
 
Considering that gingipains have been shown to signal through protease activated 
receptors (PARs; Lourbakos et al., 2001), and PAR-2 activating peptides have been 
shown to promote fibronectin expression in human lung fibroblasts, we investigated the 
role PARs played in this system. Using a series of PAR antagonists, we systematically 
tested the role of PAR-1, 2, or 4 (Fig. 2).  ENMN-1068 (Enzo Life Sciences), a selective 
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PAR-2 antagonist, completely abrogated the induction of the fibronectin gene via RgpB 
or HRgpA, suggesting that Arg specific gingipains cleave PAR-2 to stimulate fibronectin 
expression, whereas the PAR-1 and PAR-4 antagonists had no effect.  Consistent with a 
role for PAR-2, we observed induction of fibronectin gene expression in cells treated 
with a PAR-2 agonist (Fig. 2).  No observed effects were noted when gingipains were 
treated with a specific inhibitor or with the PAR antagonists.  
 
Figure 2. Gingipains induce fibronectin gene expression via PAR-2. NIH 3T3 
fibroblasts (1.5x105 cells were pretreated with either AC55541 (PAR-2 agonist), BMS-
200261 (PAR-1 antagonist), ENMN 1068 (PAR-2 antagonist), and trans-cinnamoyl-Tyr-
Pro-Gly-Lys-Phe-NH2 (PAR-4 antagonist). Cells were subsequently treated with RgpB, 
HRgpA, or RgpB and HRgpA with KYT-1 inhibitor. Readings were taken after 6 hours 
of incubated at 37°C. Data depicted as means ±SD. Overall P<0.0001 (One-way 
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ANOVA). Bars and asterisks indicated post-hoc comparison significance when compared 
to control (P<0.05). 
 
Next, we confirmed if increased promoter activity corresponded with an increase 
in secreted fibronectin protein.  Exposure of NIH 3T3 cells to RgpB for 24 hours resulted 
in approximately a 2-fold increase in fibronectin protein accumulation as determined by 
densitometry readings of the blot normalized against GAPDH at a concentration of 50 
nm; concentrations of 100 or 200 nm of RgpB caused no additional increase of 
fibronectin (Fig. 2A and B).  In contrast, HRgpA did not increase fibronectin protein 
expression. HRgpA caused fibronectin fragmentation as determined by western blot (Fig. 
2C).  This might be related to the up-regulation of matrix metalloproteinase since RgpB 
increased MMP-9 related gelatinolytic activity as determined by gelatin zymography 
from NIH 3T3 fibroblasts cell culture supernatants (Fig. 3D).  
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 Figure 3. Gingipains induce fibronectin protein expression and MMP-9 activity. 
Western blot and gelatin zymography analysis. (A) Optical densities obtained from 
western blot shown in (B) depicted as fold increase over control (GAPDH) form NIH 
3T3 fibroblasts treated with 50, 100 or 200 nm of RgpB, means ± SD depicted. P=0.019 
(one-way ANOVA). (B) Western blot of fibronectin and GAPDH from NIH 3T3 Cells 
treated with RgpB for 24 hours (75μg total protein). (C) Western blot ran of a gradient 
gel for analysis of fibronectin fragmentation by 50, 100 and 200nm of HRgpA. (D) 
Gelatin zymography of NIH 3T3 cell culture supernatants depicting relative activity of 
MMP-9. NIH 3T3 cells were treated with 100nm of RgpB for 2, 4, 6 or 24 hours and with 
KYT-1 inhibitor. Gels were stained with 0.5% coomasie blue followed by destaining with 
50% methanol. The gels were dried onto cellophane and scanned under a densitometer 
for determination of gelatinolytic activity. Data depicted as means ± SD. Overall 
P=0.0223 (One-way ANOVA). Data was normalized against total protein concentration 
(Bradford method). Asterisk indicated post-hoc comparison significance when compared 
to control (P<0.05). 
 
Transforming Growth Factor β-1, a pro-fibrotic growth factor known for its 
ability to stimulate the expression of fibronectin and other tissue remodeling genes, 
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further enhanced the stimulatory effect of the gingipains (Fig. 4). As expected, purified 
TGF-β had a statically significant dose-dependent response on the fibronectin promoter 
in NIH 3T3 cells.  Interestingly, when fibroblasts were treated with both TGF-β and with 
RgpB or HRgpA, and additive effect was observed in fibronectin promoter activity. The 
relative effect of the gingipains appeared to be attenuated in the presence of KYT-1. 
Important to note, however, we cannot rule of if gingipains induce TGF-β themselves, 
additional experimentation testing this is warranted. 
 
Figure 4. Transforming Growth Factor β and Porphyromonas gingivalis gingipains 
have an additive effect on activity of the human fibronectin promoter. NIH 3T3 cells 
(1.5x105 cells) were treated with varying amounts of TGF-β or gingipains with and 
without KYT-1 inhibitor. Means are reported ± SD. (Overall P<0.001, One-way 
ANOVA). Bars and asterisks indicated post-hoc comparison significance (P<0.05). 
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Gingipains stimulate fibroblasts to produce a pro-inflammatory matrix 
 Having established that gingipains stimulate fibronectin production in fibroblasts, 
we set out to investigate the implications of this with regards to inflammation.  To this 
end, we first tested the effect of gingipains on IL-1β expression in U937 human 
monocytic cells transfected with the human IL-1β gene promoter fused to a luciferase 
reporter gene.  As depicted in Figure 5, both RgpB and HRgpA stimulated IL-1β 
expression.  Interestingly, this effect was further enhanced when cells were co-stimulated 
with gingipains and fibronectin EDA, a splicing variant of fibronectin implicated in tissue 
disrepair.  Others have demonstrated that fibronectin EDA stimulates immune cells by 
actions on TLR4 [97]  Consistent with this, we found that a selective TLR-4 blocker, 
CLI-095, inhibited the additive effect of fibronectin EDA (Figure 5).   
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Figure 5. Fibronectin-EDA and gingipains have an additive effect on the IL-1β 
promoter which is in part mediated by toll-like receptor 4. Cells were treated with 
purified FN-EDA (10, 50 or 100 ng/ml), gingipains (100nm), gingipains plus KYT-1 
(10μm), CLI-095 (InvivoGen, San Diego, CA; TLR-4 Receptor signaling inhibitor), or a 
combination. Means are reported ± SD. P< 0.0001 (One-way ANOVA); bars and 
asterisks indicated post-hoc comparison significance compared to control (P<0.05).  
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Figure 6. Gingipains induce FN-EDA expression. Immuflourescence staining of 
fibronectin-EDA from primary gingival fibroblasts. Primary gingival fibroblasts (1000 
cell/well) were treated with either 100nm of RgpB, HRgpA with and without with out 
KYT-1 inhibitor (10μM) and probed with FN-EDA primary antibody (1:200) 24 hours 
post treatment. Alexa flour 488 was used as a secondary detection antibody (1:500). (A) 
Untreated primary gingival fibroblasts. (B) Secondary IgG control (C) Gingipains + 
KYT-1. (D) RgpB treated cells. (E) HRgpA treated cells. (F) 40x micrograph from box in 
E. (G) Gingipains induce a pro-inflammatory extracellular microenvironment. 
Extracellular matrices were isolated from primary fibroblasts after 5 days of growth. 
Isolated matrices were then pretreated with 100nm of RgpB, HRgpA with or without 
KYT-1 for 24 hours. Wells were copiously washed with PBS. U937 cells permanently 
transfected with the human IL-1β promoter fused to a luciferase reporter gene were then 
cultured onto the pre treated extracellular matrices from primary fibroblasts and FN-EDA 
null fibroblasts. Data depicted as means ± SD. Bars indicate post-hoc multiple 
comparisons significance. (H) RT-PCR of FN-EDA gene from primary fibroblasts.  
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We then tested the impact of fibroblast-derived matrices on the expression of 
cytokines IL-6 and IL-8.  Cultured primary fibroblasts were allowed to deposit a matrix. 
Afterwards, the fibroblasts were eliminated via a series of washes; the newly derived 
matrices were cleared of possible contaminants with PBS and then treated with 
gingipains. After another thorough washing, U937 were cultured atop followed by 
analysis of IL-6 and IL-8 protein content in the conditioned media using enzyme-linked 
immunoassay.  As a control, plastic did not show up-regulation of IL-6 or IL-8 (Figure 
7A and D).  However, U937s showed increased IL-6 and IL-8 protein secretion when 
cultured atop of matrices derived from fibroblasts treated with either gingipain (Figure 
7A and B).  This effect appeared mediated by fibronectin EDA present in the matrix since 
matrices derived from fibroblasts unable to produce fibronectin EDA (FN-EDA null) did 
not stimulate cytokine expression in U937 cells nearly to the same amount as their wild 
type counterparts. Immunoflourescent microscopy confirmed that primary fibroblasts 
treated gingipains increased expression of secreted fibronectin-EDA (figure 6).  
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Figure 7. ECMs pretreated with gingipains induce pro-inflammatory cytokine 
production. ELISA of IL-6 and IL-8 secreted from U937 cells cultured on isolated 
primary fibroblasts extracellular matrices treated with gingipains. (A) Extracellular 
matrices were isolated from primary fibroblasts after 5 days of growth. Isolated matrices 
were then treated with 100nm of RgpB, HRgpA with or without KYT-1 for 24 hours. 
Wells were copiously washed with PBS. U933 cells were cultured on isolated matrices 
for 24 hours. Cell culture supernatants were analyzed for human IL-6. Data is depicted as 
means ±SD. P<0.0001. Bars indicate post-hoc multiple comparisons significance. (B) 
Extracellular matrices were isolated from primary fibroblasts after 5 days of growth. 
Isolated matrices were then pretreated with 100nm of RgpB, HRgpA with or without 
KYT-1 for 24 hours. Wells were copiously washed with PBS. U937 cells were cultured 
on pre treated isolated matrices for 24 hours. Cell culture supernatants were analyzed for 










  An essential component of the pathogenesis of periodontal disease is the 
destruction of the extracellular matrix (ECM). We hypothesize periodontal pathogens, 
such as P. gingivalis modulate the expression of ECM proteins to promote colonization, 
disease progression, and as a consequence jeopardize host wound healing and immunity. 
Tissue damage caused by infection leading to periodontal pocket formation allows for 
ECM exposure and thus fibronectin and pathogen interaction. Alterations in fibronectin 
expression and variations in the gene sequence have been associated with many diseases 
[156, 157]. Furthermore, P. gingivalis anchoring to fibronectin may be essential for the 
pathogenesis of periodontal disease and other disease where P. gingivalis is a culprit; 
especially considering P. gingivalis fimbriae preferentially bind to fibronectin (and 
collagen) [158]. In addition, gingipains have been reported to bind to immobilized 
fibronectin in vitro [49]. Interestingly, P. gingivalis Arg-aa gingipains affect fibronectin 
even at the genomic level, that is, RgpB and HRgpA cause an increase in the 
transcription of the human fibronectin promoter. Importantly, this effect was dependent 
on the proteolytic activity of HRgpA and RgpB, suggesting that the specificity towards 
Arg residues may elicit increasing fibronectin transcription. Previous studies have 
demonstrated that gingival fibroblasts co-cultured with P. gingivalis culture supernatants 
lead to a rapid loss of fibronectin and α5β1 integrin from cell surfaces [109], our 
observation of increased fibronectin promoter activity could thus be a compensation 
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mechanism.   Considering gingipains have already been shown to signal through PARs 
[76, 159], and PAR-2 activating peptides have been shown to stimulate fibronectin 
expression in human lung fibroblasts, investigation PARs was completed using a series of 
PAR antagonists. Interestingly, when using a potent selective PAR-2 antagonist, RgpB 
and HRgpA induced fibronectin promoter activity was completely abrogated. 
 Destruction of secreted and over-expression fibronectin can jeopardize host tissue 
integrity and cause chemotaxis and inflammation. However, not all P. gingivalis 
gingipains have the same effect on secreted fibronectin. Stimulation of the fibroblasts 
with RgpB caused a corresponding two-fold increase in secreted matrix fibronectin, as 
determined by western blot analysis. Conversely, HRgpA, which has a similar catalytic 
domain to RgpB, caused fragmentation of fibronectin at the same experimental 
concentrations, yet caused a similar increase in the transcription of the fibronectin 
promoter. This was confirmed by western blot. This differential affinity towards 
fibronectin is most likely due to the presence of the hemaglutinin domains in the HRgpA 
complex, which bind fibronectin facilitating proteolytic fragmentation. Our results of 
HRgpA dependent fibronectin fragmentation are consistent with the results of Ruggiero 
and others [108]. The presence of the hemaglutinin adhesion domain may serve as an 
important anchoring device to the extracellular milieu within the periodontal pocket.  
 Inflammatory mediators produced by immune cells and mucosal cells, alike, 
tightly regulate periodontal tissue homeostasis [160]. However, if chronic stimulation of 
the immune system either by periodontal pathogens or byproducts of periodontal 
infection, such as fibronectin fragments, can cause an unbalanced response in which host 
proteases become over stimulated, including MMPs. In fact, MMP-1, MMP-2, MMP-3, 
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MMP-8, MMP-9 and MMP-12 have been shown to contribute to tissue remodeling 
during periodontal infection [161]. Furthermore, both Arg- and Lys- gingipains have 
been shown to contribute to extracellular matrix metalloproteinase inducer (EMMPRIN), 
or CD147 shedding which can cause induction of inflammatory cytokines and MMPs.  
 Many studies have investigated the direct effect gingipains and proteases have on 
the extracellular matrix-fibroblasts dichotomy. First, gingipains can cleave fibronectin in 
the major cell-binding domain. Secondly, gingipains can also increase the anti-adhesive 
activity of tenascin C [108]. However, there is currently no data available on fibroblasts 
produced extracellular matrices treated with gingipains and immune cell interactions. Our 
data demonstrated that ECMs isolated and treated with gingipains can directly increase 
the IL-1β promoter activity and IL-6 and IL-8 protein secreted from U937 cells. 
Furthermore, fibroblasts that did not secrete FN-EDA had a less profound pro-
inflammatory effect from the U937 cells. Considering this, it is easy to see how the 
production of a pro-inflammatory extracellular matrix can further potentiate the pro-
inflammatory state in periodontitis. Not only are the ECM-fibroblasts interactions via 
integrins undermined from gingipains, which was not tested in this study [108], but also 
the actions of gingipains on the matrix itself lead to a proinflammatory state that can 
essentially act as a positive feedback loop of disrepair, tissue destruction and disease 
progression. Indeed, investigation of ECM, cell, and integrin cross talk could be a 
compelling avenue of research.  
 
This is the first report to demonstrate that gingipains have a genomic effect on the 
fibronectin gene. The increased expression of fibronectin and fragmentation would allow 
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for increased colonization, tissue breakdown and increase in fermentable fuel for P. 
gingivalis. Furthermore, gingipains act on host fibroblasts to produce fibronectin which, 
when fragmented, stimulates immune cell chemotaxis and activation. In addition, ECMs 
that have been treated with gingipains stimulate base-line proinflammatory cytokines that 
could also potentially increase host-protease activity and disease progression. Further 
investigation is warranted into the exact mechanisms surrounding FN-EDA, PAR-2 and 
TLR-4 in vivo.  
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